|1.||Tolivia, Jorge: 7 articles (07/2015 - 12/2003)|
|2.||Navarro, Ana: 7 articles (07/2015 - 12/2003)|
|3.||Rassart, Eric: 7 articles (05/2015 - 12/2003)|
|4.||Ordóñez, Cristina: 6 articles (07/2015 - 08/2008)|
|5.||Søiland, Håvard: 5 articles (02/2011 - 01/2007)|
|6.||Baak, Jan P A: 5 articles (02/2011 - 01/2007)|
|7.||González, L O: 5 articles (06/2007 - 01/2000)|
|8.||Vizoso, F: 5 articles (02/2001 - 01/2000)|
|9.||del Valle, Eva: 4 articles (07/2015 - 03/2010)|
|10.||Skaland, Ivar: 4 articles (02/2011 - 03/2008)|
01/01/2007 - "For example, the gene encoding apolipoprotein D, which is known to enhance resistance to cell stress, was expressed at significantly greater levels in benign epithelium associated with high-grade versus low-grade cancers. "
08/10/2005 - "Immunohistochemical studies confirmed a decreased Apo D expression in poorly differentiated tumors. "
08/10/2005 - "The Apo D gene-expression in tumor tissue was significantly lower than that in nontumor tissue (p = 0.011). "
12/01/2003 - "Elevated apolipoprotein D (apoD) levels are associated with reduced proliferation of cancer cells. "
06/01/2003 - "In addition, the percentage of Apo D-positive tumors was positively and significantly correlated with Clark's level of invasion (P = 0.046). "
03/19/2010 - "Elevated brain levels of apolipoprotein D (ApoD) correlate with improved neurological recovery after experimental stroke. "
01/01/2014 - "Variations in apolipoprotein D and sigma non-opioid intracellular receptor 1 genes with relation to risk, severity and outcome of ischemic stroke."
03/01/2008 - "Apolipoprotein D is elevated in oligodendrocytes in the peri-infarct region after experimental stroke: influence of enriched environment."
03/19/2010 - "Effects of chronic Clozapine administration on apolipoprotein D levels and on functional recovery following experimental stroke."
04/04/2006 - "Increased Apolipoprotein D (ApoD) expression has been reported in various neurological disorders, including Alzheimer's disease, schizophrenia, and stroke, and in the aging brain . "
|3.||Type 2 Diabetes Mellitus (MODY)
12/01/1992 - "A number of candidate genes have been studied with the aim of demonstrating either association or linkage with the disease; in South Indians the only positive results thus far have been associations between non-insulin-dependent diabetes mellitus and the genes for insulin, apolipoprotein D and complement component C4B. "
08/01/1994 - "After a recently described association between the apolipoprotein-D (Apo-D) gene polymorphism and non-insulin-dependent diabetes mellitus by our group, we have now looked at a TaqI polymorphism of the Apo-D gene in two other components of syndrome X, namely obesity and hyperinsulinemia. "
|4.||Breast Neoplasms (Breast Cancer)
09/01/1999 - "This study analysed the expression of Apo D in men with gynaecomastia or breast cancer, and evaluated its use as a prognostic marker in breast cancer. "
02/01/2009 - "Apolipoprotein D predicts adverse outcome in women >or=70 years with operable breast cancer."
03/01/2008 - "Apolipoprotein D (ApoD) is a promising prognostic and predictive factor in breast cancer, but the analysis methods and results vary. "
03/01/2008 - "Comparison of apolipoprotein D determination methods in breast cancer."
01/01/2007 - "Emerging concepts of apolipoprotein D with possible implications for breast cancer."
|5.||Prostatic Neoplasms (Prostate Cancer)
02/01/2004 - "The presence of high levels of immunoreactive Apo-D in HGPIN and prostate cancer, but not in non-malignant epithelial cells, is consistent with HGPIN being an intermediate lesion in the transition to prostate cancer, and suggests that cellular Apo-D expression is a marker of malignant transformation of the prostate."
02/01/2004 - "The median (range) percentage cellular area of HGPIN immunopositive for Apo-D (9.7%, 0-42.9), and the cellular concentration of Apo-D (MIOD 3.1, 0-13.3), were intermediate between that of normal (area 0%, 0-53.5%, MIOD 0, 0-12.6) and early stage prostate cancer tissues (area 29.2%, 0-90.8%, MIOD 6.7, 0-28.1). "
02/01/2004 - "Apolipoprotein-D: a novel cellular marker for HGPIN and prostate cancer."
02/01/1998 - "Cellular distribution of Apo-D, PSA and AR in 30 stage A/B prostate cancers and in non-malignant glandular tissue contained in the same sections was detected immunohistochemically, and staining was evaluated by computerized video image analysis. "
08/01/1995 - "Elevated Apo-D staining is associated with advanced prostate cancer."
|1.||Complement System Proteins (Complement)
|3.||Apolipoproteins D (Apo D)
|4.||Androgen Receptors (Androgen Receptor)
|5.||Messenger RNA (mRNA)
|8.||Interleukin-6 (Interleukin 6)
|10.||Staphylococcal Protein A (A, Protein)